Improving adherence in osteoporosis: a new management algorithm for the patient with osteoporosis

被引：10

作者：

Baio, Gianluca ^{[2
,10
]}

Barbagallo, Mario ^{[3
]}

D'Avola, Giovanni ^{[4
]}

Di Luccio, Andrea

Di Tanna, Gian Luca ^{[5
]}

Falaschi, Paolo ^{[6
]}

Iolascon, Giovanni ^{[7
]}

Malavolta, Nazzarena ^{[8
]}

Robbiati, Federico ^{[9
]}

Ulivieri, Fabio Massimo ^{[1
]}

机构：

[1] Osped Maggiore, Policlin IRCCS, Fdn Ca Granda, UO Med Nucl, Milan, Italy

[2] UCL, Dept Epidemiol & Publ Hlth, London, England

[3] Univ Palermo, Dept Internal Med & Emergent Pathol, Geriatr Unit, Palermo, Italy

[4] Serv Reumatol Osteoporosi Azienda, Catania, Italy

[5] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy

[6] Univ Roma La Sapienza, S Andrea Hosp, Dept Aging Sci, I-00189 Rome, Italy

[7] Univ Naples 2, Dept Orthoped & Rehabil, Naples, Italy

[8] Univ Bologna, Hosp Policlin S Orsola Malpighi, Bologna, Italy

[9] Novartis Pharmaceut, Origgio, Italy

[10] Univ Milano Bicocca, Dept Stat, Milan, Italy

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2011年 / 12卷 / 02期

关键词：

ACUTE MYOCARDIAL-INFARCTION; POSTMENOPAUSAL OSTEOPOROSIS; ORAL BISPHOSPHONATES; MEDICATION ADHERENCE; FRACTURE OUTCOMES; CLINICAL-PRACTICE; ZOLEDRONIC ACID; PERSISTENCE; THERAPY; WOMEN;

D O I：

10.1517/14656566.2011.537259

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Areas covered: We review available data and propose a new approach to improve adherence to osteoporosis therapy in clinical practice. We present the current evidence and personal experience from a group of Italian osteoporosis experts. Expert opinion: To improve adherence, we propose a multifaceted approach, which includes the Triad Model suggested by the World Health Organization, direct observed therapy and the use of drugs with longer administration intervals, e.g., zoledronic acid. The integration of these strategies may provide the basis for a marked increase in adherence to osteoporosis therapy, and improved clinical outcomes in a real-life scenario.

引用

页码：257 / 268

页数：12

共 64 条

[1] Guidelines for the diagnosis, prevention and treatment of osteoporosis
Adami, S.
Bertoldo, F.
Brandi, M. L.
Cepollaro, C.
Filipponi, P.
Fiore, E.
Frediani, B.
Giannini, S.
Gonnelli, S.
Isaia, G. C.
Luisetto, G.
Mannarino, E.
Marcocci, C.
Masi, L.
Mereu, C.
Migliaccio, S.
Minisola, S.
Nuti, R.
Rini, G.
Rossini, M.
Varenna, M.
Ventura, L.
Bianchi, G.
[J]. REUMATISMO, 2009, 61 (04) : 260 - 284
[2] [Anonymous], PURS HIGH QUAL DOTS
[3] BAIO G, 2009, ISPOR 12 ANN EUR C 2
[4] Loss of treatment benefit due to low compliance with bisphosphonate therapy
Beest, F. J. A. Penning-van
Erkens, J. A.
Olson, M.
Herings, R. M. C.
[J]. OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) : 511 - 517
[5] Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance
Boonen, S.
Vanderschueren, D.
Venken, K.
Milisen, K.
Delforge, M.
Haentjens, P.
[J]. JOURNAL OF INTERNAL MEDICINE, 2008, 264 (04) : 315 - 332
[6] *BOST CONS GROUP, 2003, HIDD EP FIND CUR UNF
[7] Simultaneous comparison of multiple treatments: combining direct and indirect evidence
Caldwell, DM
Ades, AE
Higgins, JPT
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2005, 331 (7521): : 897 - 900
[8] Zoledronic acid and secondary prevention of fractures
Calis, Karim Anton
Pucino, Frank
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (18) : 1861 - 1862
[9] The impact of compliance with osteoporosis therapy on fracture rates in actual practice
Caro, JJ
Ishak, KJ
Huybrechts, KF
Raggio, G
Naujoks, C
[J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 (12) : 1003 - 1008
[10] The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: A randomized controlled
Clowes, JA
Peel, NFA
Eastell, R
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (03) : 1117 - 1123

← 1 2 3 4 5 6 7 →